Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP. Biomol Biomed [Internet]. 2024 Dec. 11 [cited 2025 Jul. 1];25(1):29–41. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10833